Cobitolimod for moderate-to-severe, left-sided ulcerative colitis (CONDUCT): a phase 2b randomised, double-blind, placebo-controlled, dose-ranging induction trial - The Lancet

Cobitolimod for moderate-to-severe, left-sided ulcerative colitis (CONDUCT): a phase 2b randomised, double-blind, placebo-controlled, dose-ranging induction trial  The Lancet

Comments

Post a Comment

Popular posts from this blog

Blood Clots Per Rectum in a Pediatric Patient With Salmonella Enteritis: A Case Report - Cureus

Image
Infection is a common cause of hematochezia in children. While infectious diarrhea can present with bloody stools, it is rare to have the passage of frank blood clots per rectum in the pediatric population. This is a case of a seven-year-old male who presented with vomiting, diarrhea, severe abdominal pain, and passage of blood clots per rectum. As symptoms progressed, consideration of non-infectious causes was investigated and subsequently ruled out. The stool polymerase chain reaction (PCR) was positive for Salmonella species, while stool culture was negative for any enteropathogen. This report highlights the unusual occurrence of the passage of blood clots per rectum in a child with salmonella enterocolitis. Introduction Acute gastroenteritis is a frequent cause of outpatient visits and hospitalizations in the USA, causing about 500,000 hospitalizations, and more than 5,000 deaths. While the most common cause of hematochezia in the pediatric population is infectious, a var...
Read more

Mysterious Morel Mushrooms at Center of Food Poisoning Outbreak - Kaiser Health News

Image
A food poisoning outbreak that killed two people and sickened 51, stemming from a Montana restaurant, has highlighted just how little is known about morel mushrooms and the risks in preparing the popular and expensive delicacy. The FDA conducted an investigation into morel mushrooms after the severe illness outbreak linked to Dave's Sushi in Bozeman in late March and April. The investigation found that undercooked or raw morels were the likely culprit, and it led the agency to issue its first guidelines on preparing morels. "The toxins in morel mushrooms that may cause illness are not fully understood; however, using proper preparation procedures, such as cooking, can help to reduce toxin levels," according to the FDA guidance. Even then, a risk remains, according to the FDA: "Properly preparing and cooking morel mushrooms can reduce risk of illness, however there is no guarantee of safety even if cooking steps a...
Read more